Recital 281, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

The Commission accordingly grants Aventis Pharma and Rhône-Poulenc Biochimie a 40 % reduction of the fine that would otherwise have been imposed had it not cooperated with the Commission.

3.3.7.4. Conclusion on the application of the Leniency Notice